BusinessHeart Recovery Patients Visit Capitol Hill to Advocate for Lifesaving Cardiovascular TechnologyBy Nasdaq OMXJun 9, 2017, 12:08 PM UTC
BusinessAbiomed Introduces 3rd Generation Impella CP® Heart Pumps at SCAI 2017By Nasdaq OMXMay 9, 2017, 1:34 PM UTC
BusinessSunshine Heart hires Jim Breidenstein as Chief Commercial OfficerBy Nasdaq OMXApr 11, 2017, 10:00 AM UTC
BusinessFirst-Ever Presentation on Abiomed’s Impella® Quality (IQ) Assurance Program and Importance of Treatment Protocols to Improve Patient Survival and Heart Recovery at the 2017 American College of Cardiology Scientific SessionBy Nasdaq OMXMar 19, 2017, 6:30 PM UTC
BusinessAbiomed's Impella® Technology Showcased at 2017 American College of Cardiology Scientific Session With More Than 10 PresentationsBy Nasdaq OMXMar 16, 2017, 12:00 PM UTC
BusinessNew Study Finds Abiomed Impella® Heart Pump Reduces Injury to Kidneys During High-Risk Percutaneous Coronary InterventionBy Nasdaq OMXMar 9, 2017, 1:00 PM UTC
BusinessSunshine Heart to Partner with the American Association of Heart Failure NursesBy Nasdaq OMXFeb 27, 2017, 10:00 AM UTC
